Case Studies Efficient Project Management for a Late-Stage Parkinson’s Disease Study January 6th, 2026 1 minute read Phastar partnered with a biotechnology sponsor to manage statistical and data management activities for a late-stage ...
Case Studies Turning Legacy Complexity into Submission-Ready Confidence November 24th, 2025 1 minute read Discover how Phastar converted 16 legacy studies into SDTM and delivered a robust Integrated Summary of Safety (ISS) ...
Case Studies Delivering a Complex Integrated Summary of Effectiveness: Efficient Pooling and Advanced Analysis Across Four Multiple Sclerosis Spasticity Studies November 17th, 2025 1 minute read A sponsor needed to pool data from four MS spasticity studies—one still ongoing with another vendor—while adapting mi...
Case Studies IDAC for a Phase III Study in Thrombotic Microangiopathy: Delivering High-Quality Statistical Support Within Budget Constraints November 12th, 2025 1 minute read Phastar acted as the Independent Data Analysis Centre (IDAC) for a Phase III trial in thrombotic microangiopathy (TMA...
Case Studies Delivering an Integrated Summary of Safety: Resolving Data Inconsistencies and Complex Derivations to Support Regulatory Submission October 22nd, 2025 1 minute read Phastar supported a sponsor in preparing an Integrated Summary of Safety (ISS) for an investigational drug in sickle ...
Case Studies Delivering a Large-Scale Integrated Summary of Safety: Standardizing 30 Studies Across Multiple Phases and Indications October 22nd, 2025 2 minute read Phastar supported a sponsor in preparing an Integrated Summary of Safety (ISS) for an investigational product in faci...
Case Studies IDAC for Interim Analysis of a Phase III Study in Essential Tremor: Ensuring Precision Amid Shifting Priorities October 17th, 2025 1 minute read Interim analyses in Phase III trials are high-stakes and often come with evolving requirements and tight timelines. W...
Case Studies Optimizing DMC Management in Phase III Trials October 14th, 2025 1 minute read Navigating multi-therapeutic Phase III studies is complex. From strict blinding protocols to scheduling senior DMC me...
Case Studies Delivering Integrated Safety and Efficacy Analyses in Cushing Syndrome October 6th, 2025 1 minute read When faced with evolving analysis plans, minimal client infrastructure, and shifting output volumes, Phastar delivere...
Case Studies Delivering a Complex ISS in Autoimmune Pulmonary Alveolar Proteinosis September 26th, 2025 1 minute read Phastar supported a sponsor in delivering a high-quality Integrated Summary of Safety (ISS) for a rare disease progra...
Case Studies Delivering Integrated Efficacy and Safety Summaries in VMS September 26th, 2025 1 minute read Integrating efficacy and safety data across multiple studies is never simple—especially when patient-reported outcome...
Case Studies CRO Oversight: Restoring Quality to Outsourced Oncology and Rheumatology Studies July 16th, 2025 1 minute read After acquiring a biotech, a global pharma company faced major issues with two ongoing pharmacokinetic studies—both f...
Case Studies Delivering Scalable FSP Solutions for a Top 20 Global Pharmaceutical Company June 26th, 2025 1 minute read When a top 20 global pharmaceutical company issued a competitive RFP seeking support in statistical programming and d...
Case Studies Using Real-World Data to Predict Diabetic Complications in PRECARD study June 11th, 2025 1 minute read A new predictive tool built from NHS data helps identify patients most at risk of kidney disease and retinopathy. It ...
Case Studies Accelerating Clinical Data Review: Addressing Fragmentation, Improving Collaboration, and Reducing Review Cycle Times by 35% June 4th, 2025 1 minute read If your clinical data review process feels slow, fragmented, or error-prone, this case study shows how Phastar and Be...
Case Studies Turning Complexity into Confidence: Strategic Rescue and Long-Term Partnership in Oncology Trials May 27th, 2025 1 minute read How Phastar Rescued 12 Studies and Became a Long-Term Strategic Partner. Discover how Phastar stepped in to rescue mu...
Case Studies Enhancing Clinical Trial Recruitment with Predictive Forecasting April 23rd, 2025 1 minute read Delays in patient recruitment can derail even the most well-designed clinical trials. Discover how Phastar’s Recruitm...
Case Studies Automating Clinical Trial Monitoring: How Phastar Transformed Data Oversight and Compliance April 3rd, 2025 1 minute read A customer managing a high-profile clinical trial faced significant challenges due to their reliance on Excel for tri...
Case Studies Cyber Security Posture Report January 10th, 2023 1 minute read This project was a collaboration between Kopenhagen Konsulting and Phastar Denmark. KK Management Konsulting lead the...
Case Studies Phase III Asthma Study January 10th, 2023 1 minute read Phastar was engaged to rescue another CROs reporting of a large phase III study in mild asthmatics to evaluate the ef...
Case Studies Bayesian Network Meta-analysis December 4th, 2021 1 minute read Hepatitis B virus (HBV) infection is among the most common persistent viral infections in humans. Chronic infection o...
Case Studies Investigation into Bioequivalence Study September 3rd, 2021 1 minute read A new formulation under investigation was planned to be submitted for use in both the US and Europe. As the reference...
Case Studies IDAC Support April 6th, 2021 1 minute read Phastar was awarded as a preferred supplier to a top 20 pharmaceutical sponsor, supporting five new studies per year....
Case Studies Integrated Summary of Safety – Complexities, Communication and Completion January 25th, 2021 1 minute read Phastar was contracted to assist a pharmaceutical company with the conversion of 16 legacy studies to SDTM (2 SDTM “L...
Case Studies ISS/ISE Package August 11th, 2020 1 minute read Phastar was contracted to assist a global pharmaceutical company with their integrated summary of safety and efficacy...
Case Studies Genetic Rare Disease Program to Support Regulatory Submission August 11th, 2020 1 minute read Phastar provided a team of statisticians and programmers to deliver the analysis and reporting of a program of four t...
Case Studies Event Prediction to Guide Clinical Study Design August 11th, 2020 1 minute read Following the completion of an early phase clinical trial, the sponsor was planning a larger phase IIb study with the...
Case Studies Preferred Partnership August 11th, 2020 1 minute read Phastar began a relationship with a top ten pharmaceutical company carrying out statistical consultancy and were subs...
Case Studies Phase I-II Oncology Study August 11th, 2020 2 minute read Case study PHASTAR was engaged to report a phase I/II oncology study in advanced NSCLC with an initial phase I escala...
Case Studies Functional Service Provision August 3rd, 2020 1 minute read Phastar has a number of sponsor relationships where we provide teams of statisticians and statistical programmers to ...
